The New Vulnerabilities Equities Policy and Process Charter

An updated “Vulnerabilities Equities Policy and Process for the United States Government” charter was released on 15 NOV 2017 and describes the decision-making process for determining whether new vulnerabilities found by US government departments and agencies are disclosed or restricted.   According to the White Continue Reading

Global Weekly Executive Summary, 29 SEPT 2017

Deloitte Data Breach Multinational accounting and auditing firm Deloitte was the victim of a major cyberattack that lead to unauthorized access to the company’s internal email systems. Staff and client data was stolen, including usernames, passwords, IP addresses, business diagrams, and health information and email Continue Reading

Global Weekly Executive Summary, 22 SEPT 2017

Kaspersky Products Banned from US Federal Government Systems The US Department of Homeland Security ordered a purge of all security products originating from Russian cybersecurity company Kaspersky Lab over national security concerns. The US Department of Homeland Security (DHS) on 13 September “issued a Binding Continue Reading

Global Weekly Executive Summary, 01 SEPT 2017

Turla Group, the Gazer Backdoor, and WhiteBear Activity This week, two security researchers published reports relating to well-known cyberespionage APT group,Turla. Security researchers from ESET, an IT security company based in Slovakia, wrote about a previously undocumented backdoor called Gazer which appears to be the Continue Reading

Global Weekly Executive Summary, August 11, 2107

eLoran: New Interest in Radio Navigation Technology after GPS Jamming Incidents Recent incidents of GPS interference and jamming and the possibility of cyberattacks have renewed interest in earth-based radio navigation systems. South Korea, the US, Russia, and Britain have all independently been exploring Enhanced Long Continue Reading

NotPetya Ransomware Disrupts Merck Vaccine Production

Merck, a global leader in drug and vaccine production, may be unable to produce hepatitis B vaccines until 2018 because of worldwide production disruptions resulting from the NotPetya ransomware attacks in June. In late June 2017, Merck, one of the “big four” of the world’s Continue Reading